DK1567018T3 - Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammer - Google Patents
Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammerInfo
- Publication number
- DK1567018T3 DK1567018T3 DK02783892T DK02783892T DK1567018T3 DK 1567018 T3 DK1567018 T3 DK 1567018T3 DK 02783892 T DK02783892 T DK 02783892T DK 02783892 T DK02783892 T DK 02783892T DK 1567018 T3 DK1567018 T3 DK 1567018T3
- Authority
- DK
- Denmark
- Prior art keywords
- lactobacillus reuteri
- mammals
- strains
- immune function
- improving immune
- Prior art date
Links
- 241000186604 Lactobacillus reuteri Species 0.000 title abstract 3
- 229940001882 lactobacillus reuteri Drugs 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 2
- 230000036737 immune function Effects 0.000 title abstract 2
- 230000006041 cell recruitment Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000024033 toxin binding Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/SE2002/001903 WO2004034808A1 (en) | 2002-10-18 | 2002-10-18 | Method of improving immune function in mammals using lactobacillus reuteri strains |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1567018T3 true DK1567018T3 (da) | 2009-09-14 |
Family
ID=32105771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02783892T DK1567018T3 (da) | 2002-10-18 | 2002-10-18 | Fremgangsmåde til at forbedre immunfunktionen hos pattedyr ved anvendelse af lactobacillus reuteri stammer |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060002907A1 (da) |
EP (1) | EP1567018B1 (da) |
JP (1) | JP2006506371A (da) |
CN (1) | CN100348119C (da) |
AT (1) | ATE434940T1 (da) |
AU (1) | AU2002347697B2 (da) |
BR (1) | BR0215884A (da) |
DE (1) | DE60232827D1 (da) |
DK (1) | DK1567018T3 (da) |
ES (1) | ES2329020T3 (da) |
HK (1) | HK1079661A1 (da) |
MX (1) | MXPA05003743A (da) |
WO (1) | WO2004034808A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7955834B2 (en) * | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
ZA200705844B (en) * | 2004-12-15 | 2008-09-25 | Van Der Westhuzen Corne Floris | Detoxifying and immunity-booster composition |
US20060251634A1 (en) | 2005-05-06 | 2006-11-09 | Ho-Jin Kang | Method of improving immune function in mammals using lactobacillus strains with certain lipids |
US7374924B2 (en) * | 2006-06-05 | 2008-05-20 | Biogaia Ab | Use of selected lactic acid bacteria for reducing infantile colic |
US7910127B2 (en) * | 2007-03-02 | 2011-03-22 | Biogaia Ab | Use of lactic acid bacteria for improving food lysine absorption of pet animals |
FI121952B (fi) | 2009-05-06 | 2011-06-30 | Oriola Oy | Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi |
US20110293710A1 (en) * | 2010-02-02 | 2011-12-01 | Delphine Saulnier | Immunomodulatory properties of lactobacillus strains |
CA2946464A1 (en) | 2014-05-05 | 2015-11-12 | Giovanni Mogna | Adjunctive therapy to chemotherapy treatments for tumors, acquired immunodeficiency syndrome and leukemias |
JP6804984B2 (ja) * | 2014-05-05 | 2020-12-23 | キアラ・ベナッサイChiara BENASSAI | 腫瘍、後天性免疫不全症候群および白血病の二重免疫バイオスティミュレーションによる処置における使用のための治療剤 |
CN113073066B (zh) * | 2021-04-16 | 2022-01-04 | 段云峰 | 罗伊氏乳杆菌及其应用、组合物、药物和食品 |
CN113881597B (zh) * | 2021-10-15 | 2023-04-28 | 江南大学 | 一株能够提高吲哚丙烯酸以调节特异性IgE的罗伊氏乳杆菌 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2139107A1 (en) * | 1992-06-25 | 1994-01-06 | Walter J. Dobrogosz | Method of stimulating the immune system |
ATE239486T1 (de) * | 1995-12-21 | 2003-05-15 | Biogaia Ab | Verwendung von lactobacillus reuteri zur hemmung der kryptosporidiosis in säugetieren |
PT862863E (pt) * | 1997-01-09 | 2002-04-29 | Nestle Sa | Produto cerealifero contendo probioticos |
WO1999017788A1 (en) * | 1997-10-06 | 1999-04-15 | Abbott Laboratories | Composition of treatment of candidiasis |
US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
US7105336B2 (en) * | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
-
2002
- 2002-10-18 WO PCT/SE2002/001903 patent/WO2004034808A1/en active Application Filing
- 2002-10-18 DK DK02783892T patent/DK1567018T3/da active
- 2002-10-18 EP EP02783892A patent/EP1567018B1/en not_active Expired - Lifetime
- 2002-10-18 ES ES02783892T patent/ES2329020T3/es not_active Expired - Lifetime
- 2002-10-18 CN CNB028296958A patent/CN100348119C/zh not_active Expired - Fee Related
- 2002-10-18 JP JP2004545114A patent/JP2006506371A/ja not_active Withdrawn
- 2002-10-18 MX MXPA05003743A patent/MXPA05003743A/es active IP Right Grant
- 2002-10-18 BR BR0215884-1A patent/BR0215884A/pt not_active Application Discontinuation
- 2002-10-18 US US10/531,651 patent/US20060002907A1/en not_active Abandoned
- 2002-10-18 DE DE60232827T patent/DE60232827D1/de not_active Expired - Lifetime
- 2002-10-18 AU AU2002347697A patent/AU2002347697B2/en not_active Ceased
- 2002-10-18 AT AT02783892T patent/ATE434940T1/de active
-
2005
- 2005-12-23 HK HK05111951A patent/HK1079661A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2002347697A1 (en) | 2004-05-04 |
EP1567018A1 (en) | 2005-08-31 |
US20060002907A1 (en) | 2006-01-05 |
DE60232827D1 (de) | 2009-08-13 |
AU2002347697B2 (en) | 2008-03-20 |
ES2329020T3 (es) | 2009-11-20 |
EP1567018B1 (en) | 2009-07-01 |
HK1079661A1 (en) | 2006-04-13 |
JP2006506371A (ja) | 2006-02-23 |
CN100348119C (zh) | 2007-11-14 |
BR0215884A (pt) | 2005-12-20 |
CN1668211A (zh) | 2005-09-14 |
MXPA05003743A (es) | 2005-06-17 |
ATE434940T1 (de) | 2009-07-15 |
WO2004034808A1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1079661A1 (en) | Use of lactobacillus reuteri strains for preparingcomposition of improving immune function in mammals | |
JOP20190017B1 (ar) | أجسام مضادة ترتبط مع مستقبل cgrp بشري | |
WO2010034032A3 (en) | Methods for preparing purified polypeptide compositions | |
MX2009003306A (es) | Anticuerpos humanos que se unen a cxcr4 y sus usos. | |
HK1074670A1 (en) | Sets of digital antibodies directed against short epitopes, and methods using same | |
SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2005121331A3 (en) | Truncated galnact2 polypeptides and nucleic acids | |
WO2007041171A3 (en) | Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells | |
WO2007030642A3 (en) | Toxin conjugated eph receptor antibodies | |
WO2001021766A3 (en) | Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells | |
MX2010003574A (es) | Anticuerpos il-23. | |
AU2010217100A8 (en) | Anti-CepsilonmX antibodies capable of binding to human mIgE on B lymphocytes | |
MX351247B (es) | Composiciones inmunogenicas que comprenden polipeptidos de mycobacterium tuberculosis y fusiones de los mismos. | |
PL1682530T3 (pl) | Podstawione pirolo-indole jako inhibitory PAI-1 | |
WO2006116181A3 (en) | Regulatory t cell mediator proteins and uses thereof | |
WO2008108830A8 (en) | Immunogenic and therapeutic compositions for streptococcus pyogenes | |
TN2009000380A1 (en) | Novel human anti-r7v antibodies and uses thereof | |
ATE522541T1 (de) | Bakterielle adhäsine konformere | |
WO2008085962A3 (en) | Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants | |
WO2003075953A3 (en) | Immunomodulatory polymeric antigens for treating inflammatory pathogies | |
WO2008016730A3 (en) | Compositions and methods for reducing cellular fat | |
MX2007011381A (es) | Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion. | |
MX2010002773A (es) | Antigenos mutantes de gas57 y anticuerpos de gas57. | |
WO2007103468A3 (en) | Use of vx-702 for treating rheumatoid arthritis | |
WO2006116192A3 (en) | Irta-1 antibodies and their uses |